Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 4, 2001, Pages 429-438

  Lockhart, B ^a   Closier, M ^a   Howard, K ^a   Steward, C ^a   Lestage, P ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Acetylcholinesterase; Acetylcholinesterase inhibitor; Cholinergic; Fasciculin 2; Muscarinic; Oxotremorine M

Indexed keywords

CHOLINESTERASE INHIBITOR; DRUG DERIVATIVE; FASCICULIN; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; OXOTREMORINE; OXOTREMORINE M; QUINUCLIDINYL BENZILATE; SNAKE VENOM; AMBENONIUM; EDROPHONIUM; GALANTAMINE; NEOSTIGMINE; PARATHION; PHYSOSTIGMINE; PYRIDOSTIGMINE; RADIOLIGAND; TACRINE;

ANIMAL; ARTICLE; BINDING SITE; BRAIN; DRUG EFFECT; ELECTROPHORUS; METABOLISM; RAT; ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PREDICTION;

ANIMALS; BINDING SITES; BRAIN; CHOLINESTERASE INHIBITORS; ELAPID VENOMS; ELECTROPHORUS; MUSCARINIC AGONISTS; OXOTREMORINE; QUINUCLIDINYL BENZILATE; RATS; RECEPTORS, MUSCARINIC;

EID: 0034745217     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000382     Document Type: Article

References (36)

1. Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel
2. 3H]-methylcarbamylcholine in rat brain
3. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors
4. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
5. The binding of agonists to brain muscarinic receptors
6. The character of the muscarinic receptors in different regions of the rat brain
7. New acetylcholinesterase inhibitors
8. The molecular basis of muscarinic receptor diversity
9. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors
10. 50)
11. Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: The NMS:Oxo-M ratio as an index of efficacy at cortical muscarinic receptors
12. 2 muscarinic receptors
13. 3H]-Acetylcholine to muscarinic receptors: Regional distribution and modulation by guanine nucleotides
14. Crystal structure of an acetylcholinesterase-fasciculin complex: Interaction of a three-fingered toxin from snake venom with its target
15. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum
16. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions
17. High-affinity activation by paraoxan of a muscarinic receptor subtype in rat brain striatum
18. Muscarinic toxins from the black mamba Dendroaspis polylepis
19. Organophosphate-induced alterations in muscarinic receptor binding and phosphoinositide hydrolysis in the human SK-N-SH cell line
20. High affinity binding of [3H]acetylcholine to muscarinic cholinergic receptors
21. Allosteric antagonists of the muscarinic acetylcholine receptors
22. Direct actions of anticholinesterases on the neuronal nicotinic acetylcholine receptor channels
23. Cognitive enhancement therapy for Alzheimer's disease: The way forward
24. Physostigmine and galanthamine: Probes for a novel binding site on the α4β2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells
25. 1 muscarine receptors
26. Human muscarinic receptors expressed in A9L and CHO cells: Activation by full and partial agonists
27. 3H]-Oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: Use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist and antagonist classes
28. The reversible cholinesterase inhibitor physostigmine has channel blocking and agonist effects on the acetylcholine receptor ion-channel complex
29. Anticholinesterase drugs stimulate phosphatidylinositol response in rat tracheal slices
30. Cholinergic therapies in Alzheimer's disease
31. Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases
32. Modification of the binding properties of muscarinic receptors by gallamine
33. Muscarinic receptor subtype involvement in brain cholinergic stimulation by intracerebroventricular neostigmine in sinoaortic denervated rats
34. Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors
35. In vitro modulation of bovine caudate muscarinic receptor number by organophosphates and carbamates
36. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors